Lista de obras -

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

artículo científico publicado en 2016

Adjuvants for HIV vaccines

artículo científico publicado en 2016

Adjuvants for human vaccines

artículo científico

Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial

artículo científico publicado en 2013

Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits

artículo científico publicado en 2009

Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores

artículo científico publicado en 2011

Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial

artículo científico publicado en 2012

Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines

artículo científico publicado en 2006

Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition

artículo científico publicado en 2016

Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge

scientific article published on 01 May 2020

Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research

artículo científico publicado en 2015

Control of Heterologous Simian Immunodeficiency Virus SIV Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques

artículo científico publicado en 2018

Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen

artículo científico publicado en 2006

Depletion of cellular cholesterol interferes with intracellular trafficking of liposome-encapsulated ovalbumin

artículo científico publicado en 2003

Designing a soluble near full-length HIV-1 gp41 trimer

artículo científico publicado en 2012

Detection of antibodies to squalene: III. Naturally occurring antibodies to squalene in humans and mice

artículo científico publicado en 2004

Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region

scientific article published on 14 December 2015

Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition

artículo científico publicado en 2020

Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.

artículo científico publicado en 2018

HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions

scientific article published on 30 January 2020

HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responses

artículo científico publicado en 2012

HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development

artículo científico publicado en 2013

HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies

artículo científico publicado en 2006

Highly effective generic adjuvant systems for orphan or poverty-related vaccines

artículo científico publicado en 2010

Human erythrocytes selectively bind and enrich infectious HIV-1 virions

artículo científico publicado en 2009

Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation

scientific article published on 29 April 2009

Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor

artículo científico publicado en 2015

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

artículo científico publicado en 2012

Immunization with DNA through the skin ⬇️

artículo científico publicado el 1 de noviembre de 2003

Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary

artículo científico publicado en 2015

In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins

artículo científico publicado en 2005

Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells

artículo científico publicado en 2002

Isolation and purification of proteasomes from primary cells

artículo científico publicado en 2014

Liposomal adjuvants for human vaccines

artículo científico publicado en 2016

Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines

artículo científico

Microscale purification of antigen-specific antibodies

artículo científico publicado en 2015

Modulation of dengue virus infection of dendritic cells by Aedes aegypti saliva

artículo científico publicado en 2004

Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge

artículo científico publicado en 2015

Multicomponent anthrax toxin display and delivery using bacteriophage T4.

artículo científico publicado en 2006

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

artículo científico publicado en 2017

Prevalence, treatments and outcomes of coronary artery disease in Indians: A systematic review

artículo científico publicado en 2015

Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys ⬇️

scientific article published on 24 October 2013

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection

artículo científico publicado en 2017

TFH cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1

artículo científico publicado en 2015

The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.

artículo científico publicado en 2012

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

artículo científico publicado en 2013

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

artículo científico publicado en 2012

Lista de obras de

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

Adjuvants for HIV vaccines

Adjuvants for human vaccines

Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial

Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits

Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores

Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial

Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines

Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition

Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge

Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research

Control of Heterologous Simian Immunodeficiency Virus SIV Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques

Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen

Depletion of cellular cholesterol interferes with intracellular trafficking of liposome-encapsulated ovalbumin

Designing a soluble near full-length HIV-1 gp41 trimer

Detection of antibodies to squalene: III. Naturally occurring antibodies to squalene in humans and mice

Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region

Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition

Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.

HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions

HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responses

HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development

HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies

Highly effective generic adjuvant systems for orphan or poverty-related vaccines

Human erythrocytes selectively bind and enrich infectious HIV-1 virions

Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation

Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

Immunization with DNA through the skin ⬇️

Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary

In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins

Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells

Isolation and purification of proteasomes from primary cells

Liposomal adjuvants for human vaccines

Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines

Microscale purification of antigen-specific antibodies

Modulation of dengue virus infection of dendritic cells by Aedes aegypti saliva

Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge

Multicomponent anthrax toxin display and delivery using bacteriophage T4.

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

Prevalence, treatments and outcomes of coronary artery disease in Indians: A systematic review

Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys ⬇️

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection

TFH cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1

The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys